# Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism

> **NCT04020666** · — · COMPLETED · sponsor: **The Second Hospital of Hebei Medical University** · enrollment: 113 (actual)

## Conditions studied

- Acute Ischemic Stroke
- Abnormal Glucose Metabolism

## Interventions

- **DRUG:** Urinary Kallidinogenase

## Key facts

- **NCT ID:** NCT04020666
- **Lead sponsor:** The Second Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04020666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04020666, "Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04020666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*